min-117
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2018 (NCT03446846)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 1a (5-HT1a) receptorINHIBITOR
HTR1A inhibitor
- Serotonin 2a (5-HT2a) receptorINHIBITOR
HTR2A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03446846 | Phase 2 | Mar 30, 2018 | Minerva Neurosciences |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Minerva Neurosciences | For profit | 1 | 1 | 1 | 2018 |
1 organizations
Page 1 / 1